Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
64
41
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues41
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease32
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life31
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice31
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature29
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population28
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis27
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards27
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants27
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years26
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases26
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy26
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies25
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method24
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies24
Platelet Activation and Thrombosis in COVID-1924
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment24
Platelet Function Testing: Update and Future Directions23
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More22
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient22
Testing for Lupus Anticoagulants21
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease21
Fifty Years of Fibrinogen Structure and Function20
Editorial Compilation—XIII20
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives19
Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis19
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings18
The History of Rare Bleeding Disorders18
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review17
Cardiovascular Mortality after Venous Thromboembolism: A Meta-Analysis of Prospective Cohort Studies17
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L16
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future15
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice15
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review15
Platelet Function: Acute vs. Chronic Responses to Physical Exercise - A Review15
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase14
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment14
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III14
Toward 50 Years of Seminars in Thrombosis and Hemostasis14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management14
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles14
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism14
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System13
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories13
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?13
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment13
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review13
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review12
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu12
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data12
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans12
12
Automation in Platelet Function Testing: Current Challenges and Future Directions12
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale12
12
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance11
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities11
Venous Thromboembolism in Children: The Rivaroxaban Experience11
Colchicine as a Modulator of Platelet Function: A Systematic Review11
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?11
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic11
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency11
11
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics11
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls11
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives11
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials10
A Historical Perspective on the Reversal of Anticoagulants10
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review10
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome10
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer10
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis10
Editorial Compilation XIV10
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?10
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review10
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy10
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions10
9
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications9
Thrombin Generation Assays: What are the Current Clinical Applications?9
9
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis9
Precision Medicine in Rare Bleeding Disorders9
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays9
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass9
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia9
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)9
Editorial Compilation XI9
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice9
Bleeding Scoring Systems in Neonates: A Systematic Review9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles8
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?8
Platelet Physiology8
Non-factor Therapies for Hemophilia: Achievements and Perspectives8
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines8
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations8
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art8
Hemostasis Testing in the Emergency Department: A Narrative Review8
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism8
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature8
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure8
8
NETosis in Acute Thrombotic Disorders8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?7
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards7
7
Crucial Stepping Stones in Platelet History7
The More Recent History of Hemophilia Treatment7
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment7
PFA-100 System: A New Method for Assessment of Platelet Dysfunction7
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care7
Internal Quality Control in Hemostasis Assays7
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality7
The Role of Platelets in Atherosclerosis: A Historical Review7
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives7
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?7
One Hundred Years of Congenital Fibrinogen Disorders7
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke7
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-196
6
Clinical, Laboratory Aspects and Management of Factor X Deficiency6
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation6
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation6
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 50006
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research6
Next-Generation Sequencing and Emerging Technologies*6
6
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up6
Antiplatelet Therapy in Coronary Artery Disease: Now and Then6
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics6
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies6
Evolution of Antiphospholipid Syndrome6
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond6
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency6
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer6
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study6
0.10391116142273